Singapore biomedical manufacturing up by 9.6% in 2019
Compared to June 2018, the biomedical manufacturing output in Singapore city rises by 5% this month, concurrently boosting the country’s overall pharmaceuticals output growth.
Compared to June 2018, the biomedical manufacturing output in Singapore city rises by 5% this month, concurrently boosting the country’s overall pharmaceuticals output growth.
Alvotech and Cipla agree to jointly commercialize another biosimilar to AbbVie's Humira, ahead of filing with the US FDA and the EMA.